More Fields

Filters

Profiles which have:

Recent Changes

Profiles with recent changes to:
Sign up to Download

1-30 of 47 results

  • www.insidebiosimilars.com
U.S. Food and Drug Administration. Guidance for Industry: Scientific Considerations in Demonstrating Biosimilarity to a Reference Product. April 2015. Available at: https://www.fda.gov/downloads/drugs/guidances/ucm291128.pdf. Accessed November 14,..
Relevance: 79.020775
  • www.amgen.co.uk
  • 6
  • 8
Amgen is one of the world's leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses... Amgen is a pioneer in..
Relevance: 75.762886
  • www.amgenesas.com
Amgen ESAs are well-studied and a proven option for patients with anemia due to CKD 1,2... Cases of PRCA and of severe anemia, with or without other cytopenias that arise following the development of neutralizing antibodies to erythropoietin have..
Relevance: 75.02396
  • www.amgenpipeline.com
This pipeline presents a selection of the Company's product candidates and is designed to demonstrate the range of the Company's commitment to patients in pursuing therapies to treat serious illnesses. We present a selection of these product..
Relevance: 74.994965
  • www.amgeninjectiondemos.com
Learn about different injection options, and watch demonstration videos to see how each device works...
Relevance: 74.60735
  • www.kyprolis.com
Knowing your options is a powerful thing. Amgen is committed to ensuring patients have access to KYPROLIS®... Sometimes you need someone who knows what you're going through. That's why Amgen offers patients who are prescribed KYPROLIS® the Amgen..
Relevance: 74.15905
  • www.catallyst.com
Recognizing the need for a comprehensive resource on measurable residual disease (MRD)... education, Amgen Oncology engaged with several opinion leaders in acute lymphoblastic leukemia... Review the latest information and resources on acute..
Relevance: 74.15905
  • www.aimovigcopaycard.com
Before starting Aimovig®, tell your healthcare provider (HCP) about all your medical conditions, including if you are pregnant or plan to become pregnant, breastfeeding or plan to breastfeed... Approved Use: Aimovig® is a prescription medicine used..
Relevance: 74.15905
  • www.kyprolis-hcp.com
For patients ≥ 75 years, the risk of cardiac failure is increased. Patients with New York Heart Association Class III and IV heart failure, recent myocardial infarction, conduction abnormalities, angina, or arrhythmias may be at greater risk for..
Relevance: 73.61813
  • www.developingbiosims.com
The biosimilar manufacturer begins by identifying the critical quality attributes (CQAs) of the reference product and subsequently must develop manufacturing parameters that result in a highly similar product. 1-3..
Relevance: 73.61813
  • www.amgeniss.com
  • 1
Amgen is committed to serving the needs of patients facing serious illness. We work to advance this mission by developing novel therapies, and also by supporting externally sponsored clinical research. We are happy to receive, review, and respond to..
Relevance: 73.61813
  • www.imlygichcp.com
  • 1
Oncovex GM-CSF Pivotal Trial in Melanoma (OPTiM) was a phase 3, multicenter, open-label study of 436 stage IIIB, IIIC, and IV patients (previously treated and untreated). Patients had injectable, unresectable melanoma and were randomized 2:1 to..
Relevance: 73.61813
  • www.otezlapro.com
  • 4
The Amgen SupportPlus Co-Pay Card may help lower your Amgen SupportPlus product out-of-pocket medication costs. Out-of-pocket costs include co-payment, co-insurance, and deductible out-of-pocket costs. The Amgen SupportPlus Co-Pay Card does not cover..
Relevance: 73.61813
  • www.sensiparhcp.com
Upper Gastrointestinal Bleeding: Cases of gastrointestinal (GI) bleeding, mostly upper GI bleeding, have occurred in patients using calcimimetics, including Sensipar®, from postmarketing and clinical trial sources. The exact cause of GI bleeding in..
Relevance: 73.58673
  • amgentotalrewards.com
Amgen provides competitive benefit plans to support your health, life, financial well-being and career...
Relevance: 73.58673
  • www.re-path.com
  • 2
  • 1
YOU ARE NOW LEAVING THIS WEBSITE. Amgen Limited and Amgen Ireland Limited takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site...
Relevance: 73.18871
  • www.xgevahcp.com
Betty's passion is running her flower shop. For her, a bone complication* could be devastating. With XGEVA® focused on preventing them, Betty can focus on mornings in her shop. 1... Discover XGEVA® (denosumab), a bone metastases treatment that may..
Relevance: 72.74449
  • www.kyprolis-hcp.com
KYPROLIS® offers the support, education, and resources that can make a difference for you and your patients... Learn about KYPROLIS® and 4 combination treatments for relapsed/refractory multiple myeloma patients at first relapse. See Full Safety..
Relevance: 72.74449
  • www.xgevahcp.com
XGEVA® (denosumab) is a subcutaneous injection for the prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors... Discover XGEVA® (denosumab), a bone metastases treatment that..
Relevance: 72.74449
  • www.bonehealthresources.com
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human..
Relevance: 72.74449
  • www.kyprolis.com
Heart problems: KYPROLIS can cause heart problems or worsen pre-existing heart conditions. Death due to cardiac arrest has occurred within one day of KYPROLIS administration. Before starting KYPROLIS, you should have a full medical work-up (including..
Relevance: 72.74449
  • www.chemotherapy.com
  • 1
Chemotherapy (chemo) is a type of treatment that includes a medication or combination of medications to treat cancer. The goal of chemo is to stop or slow the growth of cancer cells. Chemo is considered a systemic therapy. This means it may affect..
Relevance: 71.22716
  • www.rareiscommunity.com
You are now leaving the #RAREis™ Community website. Amgen is not responsible for content or availability of third-party sites...
Relevance: 70.8633
  • www.nplate.com
† Analysis from 2021 to 2022 for Commercial and Medicare patient claims combined. Data based on IQVIA LAAD claims data. Oral OOP percent is a weighted average of claims for eltrombopag, avatrombopag, and fostamatinib disodium hexahydrate... The..
Relevance: 70.8633
  • www.biologicssuffix.com
Biosimilars, although highly similar to their reference products, are not identical to their reference products or to each other.2,3 The same holds true for interchangeable biosimilars. While a biosimilar designated as an interchangeable product can..
Relevance: 70.82539
  • www.proliapoints.com
Relevance: 69.997826
  • www.kyprolis-hcp.com
† As of the primary analysis, with a median follow-up of 17 months, the primary endpoint of improved median PFS was met. mPFS was not reached for DKd vs 15.8 months for Kd (HR=0.59; 95% CI: 0.45-0.78)... ‡ As of the primary analysis, with a median..
Relevance: 69.80403
  • www.tepezzahcp.com
  • 5
Meet several patients below as they take you on their journey with TEPEZZA. You can also experience TED through the eyes of a patient with the TED Burden Simulator... Find healthcare professional information on TEPEZZA® (teprotumumab-trbw),..
Relevance: 68.9877
  • www.amgen-pharmaceutical.com
Relevance: 59.644783
  • www.avsola.ca
  • 1
  • 2
Canada-wide coverage with over 300 sites and licensed nurses providing infusions..
Relevance: 42.961147